The clinicopathological features of CD30high PTCL, NOS patients were similar to those of ALK- ALCL patients, although CD30high PTCL, NOS patients tended to have lower platelet counts (p=0.0913) and to have a lower rate of complete or partial remission (CR/PR) (p=0.0873) (Table 2). This evidence concerns the gene ALK and anaplastic large cell lymphoma.